Acurx Pharmaceuticals (ACXP) Tops Q3 EPS by 3c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q3 EPS of ($0.24), $0.03 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Infleqtion raises Q2 revenue to $13.5M after contract restatement
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c